20453 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
Composite formulation comprising a tablet encapsulated in a hard capsule
#302COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND DIAZOXIDE AND METHODS OF USE THEREOF
#303Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#304Combinations with 2-aminoethanesulfonic acid
#305MULTI-LAYERED RELEASE FORMULATION
#306HYPERTENSION AND HYPERURICEMIA
#307PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#308Pharmaceutical Composition for Treatment of Helicobacter Pylori Associated Diseases
#309Pharmaceutical composition
#310Compounds for the treatment of autism in a baby child
#311Therapy for complications of diabetes
#312METHOD OF INHIBITING HEPATITUS C VIRUS BY COMBINATION OF A 5,6-DIHYDRO-1H-PYRIDIN-2-ONE AND ONE OR MORE ADDITIONAL ANTIVIRAL COMPOUNDS
#313Cyclic amide derivative
#314COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#3155,6-dihydro-1-pyridin-2-one compounds
#316Quinazolines as potassium ion channel inhibitors
#317Inhibitors of leukotriene production
#318C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#319Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#320COMBINATION THERAPEUTIC COMPOSITION
#321SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#322Carbazole-containing sulfonamides as cryptochrome modulators
#323Pyridazinones, method of making, and method of use thereof
#324Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions
#325BID DOSAGE REGIMEN FOR DEB025
#326Process for the preparation of taurolidine and its intermediates thereof
#327COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#328Salts of potassium ATP channel openers and uses thereof
#329Formulation for the prevention of cardiovascular disease
#330Compositions of small molecule therapeutics
#331Cyclic amide derivative
#332Therapy for complications of diabetes
#333SOLID COMPOSITIONS
#334Diazoxide For Use In The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
#335Hetero-bicyclic derivatives as HCV inhibitors
#336COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DISORDERS
#337METHODS AND COMPOSITIONS FOR AMELIORATING THIAZIDE INDUCED HYPERLIPIDEMIA
#338Methods and compositions for oral pharmaceutical therapy
#339Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions
#340Risperidone-containing PLA:PGA implants and methods of use thereof
#341METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS
#342Diazoxide For Use In The Treatment Or Prevention Of A Central Nervous System (CNS) Autoimmune Demyelinating Disease
#343Compounds for the treatment of autism
#344[1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
#3455,6-D hydro-1H-pyridin-2-one compounds
#346METHOD OF TREATMENT USING EPROSARTAN
#347SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#348Quinazolines as potassium ion channel inhibitors
#349ANTAGONISM OF HUMAN FORMYL PEPTIDE RECEPTOR FOR TREATMENT OF DISEASE
#350EPIDITHIODIOXOPIPRAZINES AND USES THEREOF IN TREATING CANCER
#351Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use
#352Quinoline derivatives as PI3 kinase inhibitors
#353Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
#354NEUROPROTECTION FROM BRAIN ANOXIA AND REPERFUSION INJURY DURING STROKE AND COMPOSITIONS OF PKG PATHWAY ACTIVATORS AND METHOD OF USE THEREOF
#3555,6-dihydro-1H-pyridin-2-one compounds
#356MULTI-LAYER TABLET COMPRISING EFFERVESCENT LAYER
#357METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
#358PHARMACEUTICAL COMPOSITIONS OF VALSARTAN
#359Dissolution properties of drug products containing olmesartan medoxomil
#360USE OF A COMBINATION OF DIAZOXIDE AND METFORMIN FOR TREATING OBESITY OR OBESITY RELATED DISORDERS
#361FIXED DOSE DRUG COMBINATION FORMULATIONS
#362Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
#363Method of improving ß-adrenergic receptor function
#364NEW PHARMACEUTICAL COMBINATIONS
#365CHLOROTHIAZIDE, CHLOROTHIAZIDE SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#366PHARMACEUTICAL FORMULATIONS OF OLMESARTAN
#367METHOD OF INHIBITING HEPATITUS C VIRUS BY COMBINATION OF A 5,6-DIHYDRO-1H-PYRIDIN-2-ONE AND ONE OR MORE ADDITIONAL ANTIVIRAL COMPOUNDS
#368TELMISARTAN AND HYDROCHLOROTHIAZIDE COMBINATION THERAPY
#369Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
#3705,6-dihydro-1-pyridin-2-one compounds
#371Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
#372TREATMENT SOLUTION AND METHOD FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS
#373Sulfamide derivatives and cosmetic use thereof
#374DISSOLUTION PROPERTIES OF DRUG PRODUCTS CONTAINING OLMESARTAN MEDOXOMIL
#375SOLID PHARMACEUTICAL COMPOSITION COMPRISING A NON-PEPTIDE ANGIOTENSIN II RECEPTOR ANTAGONIST AND A DIURETIC
#376Pharmaceutical Co-Crystal Compositions
#377Enterostatin as Therapeutic Agent for Hypoglycemia
#378SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#379ORGAN PROTECTION, PRESERVATION AND RECOVERY
#380PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE
#381USE OF DIAZOXIDE FOR SUPPRESSING THE PLASMA INSULIN LEVEL IN A MAMMAL
#382NEW COMBINATIONS
#383COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#384QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS
#385Quinoline derivatives as P13 kinase inhibitors
#386Prevention of indwelling device related infection: compositions and methods
#387Prevention of indwelling device related infection: compositions and methods
#388CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THIAZIDES AND ANGIOTENSIN-II-RECEPTOR BLOCKERS
#389Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia
#390COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE
#391METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER
#392Treatment of cancers with methylol-containing compounds and at least one electrolyte
#393TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS
#394Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
#3955,6-dihydro-1H-pyridin-2-one compounds
#396RENIN INHIBITORS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION IN OBESE PATIENTS
#397Diazoxide for the treatment of Friedreich's ataxia
#398SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#399METHOD OF TREATMENT USING EPROSARTAN
#400SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME
#401Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant
#402Methods and compositions for treating nephrogenic diabetes and insipidus
#403COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS
#404BILAYER PHARMACEUTICAL TABLET COMPRISING TELMISARTAN AND A DIURETIC AND PREPARATION THEREOF
#405METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS
#406Galenical formulations of organic compounds
#407Pharmaceutical composition
#408Solid Dosage Form of Olmesartan Medoxomil And Amlodipine
#409Modified amino acids, pharmaceuticals containing these compounds and method for their production
#410USE OF TAUROLIDINE TO TREAT TUMORS
#411Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
#412PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#413Salts of potassium ATP channel openers and uses thereof
#414PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#415Therapeutic methods that target the NCchannel
#416GLP-1 AND METHODS FOR TREATING DIABETES
#417THERAPY FOR COMPLICATIONS OF DIABETES
#418Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic
#419COMBINED PREPARATION OF A THIAZIDE DIURETIC AND A LOOP DIURETIC
#420Modulation of Hypothalamic Atp-Sensitive Potassium Channels
#421Quinoline derivatives as PI3 kinase inhibitors
#422PHARMACEUTICAL COMPOSITIONS
#423COMPOSITIONS AND METHODS FOR REDUCING CARDIOVASCULAR MORBIDITY AND/OR MORTALITY
#424Formulations of Ramipril
#425Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
#426Treatment of Breast Cancer
#427Combination Of Organic Compounds
#428Enhancement of effectiveness of 5-Fluorouracil in treatment of tumor metastases and cancer
#429Bilayer tablet comprising telmisartan and diuretic
#430Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
#431Prodrug antibiotic screens
#432Preparation of antimicrobial formulations using 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione
#433Compositions and Methods for Treating Hypertension and Inflammation
#434Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
#435COMPOSITIONS AND METHODS COMPRISING A THIAZIDE DIURETIC AND A MINERALOCORTICOID INHIBITOR
#436METHOD OF TREATING TUMORS
#437Compounds for the Treatment of Inflammation of the Central Nervous System
#438Formulations of ramipril
#439Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye
#440Method for treating resistant hypertension
#441Methods for the treatment of hypertension
#442METHODS OF USING POTASSIUM CHANNEL INHIBITING COMPOUNDS
#443Salts of potassium ATP channel openers and uses thereof
#444Method of improving beta-adrenergic receptor function
#445Combination of organic compounds
#446Compositions of stabilized ramipril in combination with another active agent
#447STABLE PHARMACEUTICAL COMPOSITIONS
#448Combinations of at1-antagonists, amiloride or triamterine, and a diuretic
#449Treatment of tumor metastases and cancer
#450Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
#451Chlorine Ion Uptake Modulators and Uses Thereof
#452Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels
#453Composition and method for treating hypertension
#454Use of taurolidine as enhancer of the complement system
#455Methods and compositions for increasing the safety and efficacy of albumin-binding drugs
#456Compositions and methods for reducing cardiovascular morbidity and/or mortality
#457Preventives/remedies for urinary disturbance
#458Sustained-release oral administration preparation of phenylalanine derivatives
#459Method of treatment for preventing or reducing tumor growth in the liver of patient
#460Method of treatment for preventing or reducing tumor growth in the liver of patient
#461Treatment of cancers with methylol-containing compounds and at least one electrolyte
#462Telmisartan and hydrochlorothiazide combination therapy
#463Drug-containing implants and methods of use thereof
#464Methods of treating tumors
#465Sulfamide derivatives and cosmetic use thereof
#466Cell migration inhibiting compositions and methods and compositions for treating cancer
#467Antiviral treatment
#468Pharmaceutical compositions comprising a selective COX-2 inhibitor and a diuretic
#469Drug efflux pump inhibitor
#470Methods and compositions for the treatment of neuropsychiatric disorders
#471Preventives/remedies for urinary disturbance
#472Compositions for enhancing memory and methods therefor
#473Glp-1 and methods for treating diabetes
#474Pharmaceutical formulations of potassium ATP channel openers and uses thereof
#475Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
#476Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
#477Method of treatment of retinal ischemia with diazoxide
#478Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
#479Fosinopril formulation
#480Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
#481Method of improving beta-adrenergic receptor function
#482Preventives/remedies for urinary disturbance
#483Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
#484Treatment of DNA viral infections
#4854-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
#486Treatment of inflammatory bowel disease
#487Treatment of mesothelioma
#488Polyhydroxylated benzene-containing compounds
#489Treatment of cancers with methylol-containing compounds and at least one electrolyte
#490Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
#491Use of type 4 phosphodiesterase inhibitors in myocardial diseases
#492Method of treating certain cancers using an estrogen agonist/antagonist
#493Method and composition for restoring diuretic and renal function
#494Methods of inhibiting metastases
#495Combination drug therapy for treating hypertension
#496Treatment and prevention of cardiovascular events
#497Medicine for inhibiting drug elimination pump
#498Synthesis of taurolidine, purity profiles and polymorphs